Extracorporeal Therapies in the Treatment of Focal Segmental Glomerulosclerosis.

Title

Extracorporeal Therapies in the Treatment of Focal Segmental Glomerulosclerosis.

Creator

Raina Rupesh; Wang Joseph; Sharma Aditya; Chakraborty Ronith

Publisher

Blood purification

Date

2020
2020-02

Description

Focal segmental glomerulosclerosis (FSGS) is one of the most frequent and severe glomerular kidney disease with frequent progression to end-stage renal disease and a high rate of recurrence in renal transplantations. Due to intolerance or resistance to the current immunomodulatory treatments, the management of FSGS is a therapeutic challenge. Over the last few years, development in extracorporeal therapies has shown potential beneficial outcomes in drug-resistant and recurrent FSGS patients. Thus, this study reviews the current literature on the use of extracorporeal therapies, such as plasma exchange therapy, immunoadsorption, and low-density lipoprotein apheresis, for the treatment of FSGS in the pediatric population.

Subject

Focal segmental glomerulosclerosis; Low-density lipoprotein apheresis; Extracorporeal therapy; Immunoadsorption; Plasma exchange

Identifier

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Format

Journal Article

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Pages

1-11

NEOMED College

NEOMED College of Graduate Studies

NEOMED Department

NEOMED Student Publications

Update Year & Number

March 2020 Update

Citation

Raina Rupesh; Wang Joseph; Sharma Aditya; Chakraborty Ronith, “Extracorporeal Therapies in the Treatment of Focal Segmental Glomerulosclerosis.,” NEOMED Bibliography Database, accessed December 2, 2021, https://neomed.omeka.net/items/show/10978.

Social Bookmarking